Found: 8
Select item for more details and to access through your institution.
Reply: Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Stellenwert der Tumornephrektomie beim metastasierten Nierenzellkarzinom.
- Published in:
- Der Urologe A, 2002, v. 41, n. 3, p. 221, doi. 10.1007/s00120-002-0202-6
- By:
- Publication type:
- Article
A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 49, n. 4, p. 342, doi. 10.1007/s00280-001-0417-z
- By:
- Publication type:
- Article
A phase II study of temozolomide in hormone-refractory prostate cancer.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Lymphknotenmetastasen beim Nierenzellkarzinom. Was bringen Operation und adjuvante Therapie?
- Published in:
- 1999
- By:
- Publication type:
- journal article
Lymph node dissection for renal cell carcinoma – the value of operation and adjuvant therapy.
- Published in:
- Der Urologe A, 1999, v. 38, n. 4, p. 326, doi. 10.1007/s001200050292
- By:
- Publication type:
- Article
Orbital tumours as a first indication of urological malignancies.
- Published in:
- BJU International, 1997, v. 79, n. 2, p. 288, doi. 10.1046/j.1464-410X.1997.08027.x
- By:
- Publication type:
- Article
Multidrug Resistance.
- Published in:
- 1996
- By:
- Publication type:
- journal article